Topic: Medicare
WHAT'S HAPPENING: Medicare will spend a year deciding whether to cover Dendreon Corp.'s prostate cancer therapy Provenge, which costs $93,000 for a course of treatment. WHO WOULD BENEFIT: Studies have shown Provenge adds four months to the lives of men with advanced ...
NEW YORK — Medicare administrators say they will take a full year to review Dendreon Corp.'s prostate cancer therapy Provenge and decide whether to cover the costly treatment. Provenge, which costs $93,000 for a course of treatment, has been widely expected to ...
Dendreon says Medicare reviews whether to cover costs of prostate cancer therapy ProvengeNEW YORK — Medicare administrators say they will take a full year to review Dendreon Corp.'s prostate cancer therapy Provenge and decide whether to cover the costly treatment. Provenge, which ...
EDITOR'S NOTE — Too much medical treatment is making many Americans sicker. This is the last story in an Associated Press six-part series that examines the phenomenon of overtreatment. By MARILYNN MARCHIONE AP Medical Writer The doctors finally let Rosaria Vandenberg go ...
WASHINGTON (Reuters) - There is not enough evidence to sort out the effect of various radiation treatments for prostate cancer patients, especially newer, so-called focused radiation, an advisory panel told the U.S. Medicare agency on Wednesday. The Center for Medicare and Medicaid ...
WASHINGTON (Reuters) - At a time of growing debate over prostate cancer treatments, U.S. Medicare officials will take a closer look at radiation therapy and its ability to reduce deaths and side effects in men. The Center for Medicare and Medicaid Services ...
New advice on prostate cancer screening stresses talking about pros, cons before decidingThe American Cancer Society revised its guidelines for prostate cancer screening on Wednesday. The advocacy group is one of many organizations that make such recommendations. Some questions and answers: Q: ...
WASHINGTON (Reuters) - Changes to Medicare, the federal health plan for the elderly, may be damaging important aspects of cancer care in the United States, according to a study released on Thursday. They found that many centers offering cancer care are losing ...
Surgery or radiation treatments may not be the best choice for most older men diagnosed with prostate cancer, a study published Tuesday has found. That's because conservative management strategies -- deferring treatment until the disease progresses -- do not appear to be ...
WASHINGTON (Reuters) - Fewer than half of all Americans trust that their health insurance plans would pay for the full costs of cancer treatment and nearly two-thirds falsely believe Medicare would not pay anything, according to a survey released on Wednesday. Nearly ...